Endoscopie 2004 Argumentaire mise en forme 2006 v2 - SNFGE

Endoscopie digestive basse : indications en dehors du dépistage en population
Organisation Study Group. Lancet
2000;356(9238):1300-6.
345. Lund JN, Scholefield JH, Grainge MJ,
Smith SJ, Mangham C, Armitage NC et al.
Risks, costs, and compliance limit colorectal
adenoma surveillance: lessons from a
randomised trial. Gut 2001;49(1):91-6.
346. Noshirwani KC, van Stolk RU, Rybicki
LA, Beck GJ. Adenoma size and number are
predictive of adenoma recurrence: implications
for surveillance colonoscopy. Gastrointest
Endosc 2000;51(4 Pt 1):433-7.
347. Martinez ME, Sampliner R, Marshall JR,
Bhattacharyya AK, Reid ME, Alberts DS.
Adenoma characteristics as risk factors for
recurrence of advanced adenomas.
Gastroenterology 2001;120(5):1077-83.
348. Baron JA, Cole BF, Mott L, Haile R,
Grau M, Church TR et al. Neoplastic and
antineoplastic effects of ß-carotene on
colorectal adenoma recurrence: results of a
randomized trial. J Natl Cancer Inst
2003;95(10):717-22.
349. Baron JA, Cole BF, Sandler RS, Haile
RW, Ahnen D, Bresalier R et al. A randomized
trial of aspirin to prevent colorectal adenomas.
N Engl J Med 2003;348(10):891-9.
350. Benamouzig R, Deyra J, Martin A, Girard
B, Jullian E, Piednoir B et al. Daily soluble
aspirin and prevention of colorectal adenoma
recurrence: one-year results of the APACC
trial. Gastroenterology 2003;125(2):328-36.
351. Gandhi SK, Reynolds MW, Boyer JG,
Goldstein JL. Recurrence and malignancy rates
in a benign colorectal neoplasm patient cohort:
results of a 5-year analysis in a managed care
environment. Am J Gastroenterol
2001;96(9):2761-7.
352. Le Bodic L, Cerbelaud C, Bouchand S,
Auffret N, Clément A, Le Bodic MF. Followup
of a cohort of colorectal adenomas treated
in 1991 and 1992. Search for parameters
related to recurrence. Gastroenterol Clin Biol
2003;27(5):466-70.
353. Hixson LJ, Fennerty MB, Sampliner RE,
Mcgee DL, Garewal H. Two-year incidence of
colon adenomas developing after tandem
colonoscopy. Am J Gastroenterol
1994;89(5):687-91.
354. Avidan B, Sonnenberg A, Schnell TG,
Leya J, Metz A, Sontag SJ. New occurrence
and recurrence of neoplasms within 5 years of
a screening colonoscopy. Am J Gastroenterol
2002;97(6):1524-9.
355. Nusko G, Mansmann U, Kirchner T,
Hahn EG. Risk related surveillance following
colorectal polypectomy. Gut 2002;51(3):424-8.
356. Spencer RJ, Melton LJ, Ready RL, Ilstrup
DM. Treatment of small colorectal polyps: a
population-based study of the risk of
subsequent carcinoma. Mayo Clin Proc
1984;59(5):305-10.
357. Atkin WS, Morson BC, Cuzick J. Longterm
risk of colorectal cancer after excision of
rectosigmoid adenomas. N Engl J Med
1992;326(10):658-62.
358. Selby JV, Friedman GD, Quesenberry CP,
Weiss NS. A case-control study of screening
sigmoidoscopy and mortality from colorectal
cancer. N Engl J Med 1992;326(10):653-7.
359. Muller AD, Sonnenberg A. Prevention of
colorectal cancer by flexible endoscopy and
polypectomy. A case-control study of 32,702
veterans. Ann Intern Med 1995;123(12):904-
10.
360. Citarda F, Tomaselli G, Capocaccia R,
Barcherini S, Crespi M. Efficacy in standard
clinical practice of colonoscopic polypectomy
in reducing colorectal cancer incidence. Gut
2001;48(6):812-5.
361. Yang G, Zheng W, Sun QR, Shu XO, Li
WD, Yu H et al. Pathologic features of initial
adenomas as predictors for metachronous
adenomas of the rectum. J Natl Cancer Inst
1998;90(21):1661-5.
362. Robertson DJ, Mott L, Baron JA.
Colorectal cancer after 'clearing' colonoscopy:
experience from 3 large adenoma
chemoprevention trials [abstract]. Am J
Gastroenterol 2003;98(9 Suppl):S123.
363. Bertario L, Russo A, Sala P, Pizzetti P,
Ballardini G, Andreola S et al. Predictors of
metachronous colorectal neoplasms in sporadic
adenoma patients. Int J Cancer
2003;105(1):82-7.
364. Winawer SJ. Appropriate intervals for
surveillance. Gastrointest Endosc 1999;49(3 Pt
2):S63-6.
365. Feingold DL, Forde KA. Colorectal
Anaes / Service des recommandations professionnelles / avril 2004
- 136 -